Early Access — free while we kick the tires
EdgarHawk

Aharon Gil

Director

Director
1 filing analyzed · 1 company · Latest 2025-12-29

Companies

Company Buys Sells Direction
Neuraxis, INC NRXS 1 0 Net buying

Activity

December 2025
2025-12-29 Neuraxis, INC NRXS
high
Buy
286,138 shares
$1,007,206
Significance 6/10

Director Aharon Gil buys 286,138 shares of Neuraxis (NRXS) at $3.52 for $1.0M in first personal stock purchase

Aharon Gil, a director, established an initial position of 286,138 shares valued at $1,007,205.76, representing his first open-market purchase in Neuraxis. The transaction occurred at $3.52 per share, and the stock has since risen to $4.20 (at the high end of its 52-week range of $1.60–$4.20), marking a +30.0% move from his entry. Across his cross-ticker trading history, his prior buy transactions averaged +26.2% 30-day returns and +107.8% 90-day returns with a 100.00% 90-day win rate, establishing a materially favorable execution pattern. However, context warrants caution: Neuraxis generated quarterly revenue of only $811,414.00, posted a full-year net income of $-2,122,796.00, and carries a $44,741,810.40 market cap—a company with negative profitability and limited revenue scale. The entry timing relative to current price at the highs, combined with the company's deeply unprofitable fundamentals, presents a contrasting picture to the insider's historical track record.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access